Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines (Q34320259)

1 August 2017

Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines (English)

1 reference

1 August 2017

2

1 reference

1 August 2017

19

Rino Rappuoli

1 reference

1 August 2017

18

Mariagrazia Pizza

1 reference

1 August 2017

7

E Richard Moxon

1 reference

1 August 2017

9

Maurizio Comanducci

1 reference

1 August 2017

10

Stefania Bambini

1 reference

1 August 2017

Marzia Monica Giuliani

20

object named as

Marzia Monica Giuliani

1 reference

1 August 2017

4

Alessia Biolchi

1 reference

1 August 2017

17

Davide Serruto

1 reference

1 August 2017

11

Alessandro Muzzi

1 reference

1 August 2017

15

Laura Santini

1 reference

1 August 2017

Giuseppe Boccadifuoco

3

object named as

Giuseppe Boccadifuoco

1 reference

1 August 2017

6

Carl Frasch

1 reference

1 August 2017

John Donnelly

1

1 reference

1 August 2017

Joel Ward

5

1 reference

1 August 2017

Maria Stella

8

1 reference

1 August 2017

William Andrews

12

1 reference

1 August 2017

Jie Chen

13

1 reference

1 August 2017

George Santos

14

1 reference

1 August 2017

Philip Boucher

16

1 reference

1 August 2017

language of work or name

English

0 references

publication date

20 October 2010

1 reference

Proceedings of the National Academy of Sciences of the United States of America

1 August 2017

1 reference

1 August 2017

107

1 reference

1 August 2017

45

1 reference

1 August 2017

19490-19495

1 reference

Advances in the development of vaccines against Neisseria meningitidis

1 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984153

Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984153

A novel phase variation mechanism in the meningococcus driven by a ligand-responsive repressor and differential spacing of distal promoter elements

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984153

Bactericidal antibody responses induced by meningococcal recombinant chimeric factor H-binding protein vaccines

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984153

Immunity to Neisseria meningitidis group B in adults despite lack of serum bactericidal antibody

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984153

Epidemic meningitis, meningococcaemia, and Neisseria meningitidis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984153

Functional and specific antibody responses in adult volunteers in new zealand who were given one of two different meningococcal serogroup B outer membrane vesicle vaccines

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984153

A universal vaccine for serogroup B meningococcus

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984153

Interlaboratory standardization of the measurement of serum bactericidal activity by using human complement against meningococcal serogroup b, strain 44/76-SL, before and after vaccination with the Norwegian MenBvac outer membrane vesicle vaccine

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984153

Neisseria meningitidis NadA is a new invasin which promotes bacterial adhesion to and penetration into human epithelial cells.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984153

Meningococcal polysaccharide-protein conjugate vaccines.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984153

Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984153

NadA, a novel vaccine candidate of Neisseria meningitidis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984153

Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984153

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984153

Human immunity to the meningococcus. V. The effect of immunization with meningococcal group C polysaccharide on the carrier state

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984153

Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984153

Human immunity to the meningococcus. II. Development of natural immunity

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984153

Human immunity to the meningococcus. I. The role of humoral antibodies

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984153

Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus.

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.1013758107

Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.1013758107

Neisseria meningitidis group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2984153

MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain

28 October 2018

1 reference

12 December 2020

Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England

1 reference

12 December 2020

Serum bactericidal activity correlates with the vaccine efficacy of outer membrane vesicle vaccines against Neisseria meningitidis serogroup B disease

1 reference

12 December 2020

Putative vaccine antigens from Neisseria meningitidis recognized by serum antibodies of young children convalescing after meningococcal disease

1 reference

12 December 2020

An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues

1 reference

12 December 2020

Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C

1 reference

12 December 2020

Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile

1 reference

12 December 2020

The concept of "tailor-made", protein-based, outer membrane vesicle vaccines against meningococcal disease

1 reference

12 December 2020

Identifiers

DOI

10.1073/PNAS.1013758107

1 reference

release_l262gscnbbhq3ipen5efux7xwa

1 August 2017

0 references

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/l262gscnbbhq3ipen5efux7xwa

24 November 2022

mapped directly with Wikidata item

PMCID

2984153

1 reference

1 August 2017

1 reference